Zhang Fang-Jie, Huang Guo-Qing, Li Jia, Xu Ji, Li Xiang-Min, Wang Ai-Min
Department of Emergency Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, People's Republic of China.
Int J Gen Med. 2021 Aug 20;14:4687-4694. doi: 10.2147/IJGM.S326270. eCollection 2021.
To determine the clinical manifestations and results of adult hemophagocytic lymphohistiocytosis (HLH) patients in our emergency department.
We retrospectively evaluated patients with HLH from 1 April 2018 to 31 December 2020. The clinical data of these patients (basic information, symptoms, vital signs, laboratory results, HLH diagnostic criteria, H Score, main treatments, outcomes) were collected.
Thirty-three patients (23 males and 10 females; 40.55±18.78 years) with 34 clinical episodes (one male had two clinical episodes and died during the second episode) were enrolled. Twenty-five patients were placed in a "survivor" group, and nine patients were categorized into a "deceased" group. Fever, splenomegaly, hemoglobin <90 g/L and platelet count <100×10/L most commonly met the diagnostic standard for HLH. The H Score results in the survival group and deceased group was 212.4±37.18 and 252.1±40.95, respectively. Viral infection was the most common reason for HLH, followed by immune-system disease and cancer. Laboratory tests showed that deceased-group patients had multiple-organ dysfunction. Multivariate logistic regression showed that the lactate dehydrogenase (lactate dehydrogenase) level (P = 0.039; odds ratio, 0.999) was significantly related to death.
In the emergency department, HLH should be considered for critically ill patients with fever, splenomegaly, low hemoglobin and low platelet count. The H Score might be useful to diagnose HLH quickly. In our study, 26.47% of HLH patients died in the emergency department, and patients with a significantly increased lactate dehydrogenase level had a markedly increased risk of death.
确定我院急诊科成人噬血细胞性淋巴组织细胞增生症(HLH)患者的临床表现及治疗结果。
回顾性评估2018年4月1日至2020年12月31日期间的HLH患者。收集这些患者的临床资料(基本信息、症状、生命体征、实验室检查结果、HLH诊断标准、H评分、主要治疗方法、治疗结果)。
共纳入33例患者(男23例,女10例;年龄40.55±18.78岁),发生34次临床发作(1例男性有2次临床发作,第二次发作时死亡)。25例患者归入“存活”组,9例患者归入“死亡”组。发热、脾肿大、血红蛋白<90 g/L和血小板计数<100×10⁹/L最常符合HLH诊断标准。存活组和死亡组的H评分结果分别为212.4±37.18和252.1±40.95。病毒感染是HLH最常见的原因,其次是免疫系统疾病和癌症。实验室检查显示,死亡组患者存在多器官功能障碍。多因素logistic回归分析显示,乳酸脱氢酶水平(P = 0.039;比值比,0.999)与死亡显著相关。
在急诊科,对于伴有发热、脾肿大、血红蛋白降低和血小板计数降低的危重症患者应考虑HLH。H评分可能有助于快速诊断HLH。在我们的研究中,26.47%的HLH患者在急诊科死亡,乳酸脱氢酶水平显著升高的患者死亡风险明显增加。